Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Alzheimer’s disease, the most common form of dementia affecting more than three million Americans a year, ...

When trying to anticipate a diagnosis of Alzheimer’s disease, testing for the disease alone is only one factor to consider; there’s also a matter of predicting the onset of symptoms. The latter is ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer's disease and other causes of cognitive decline, providing a broader understanding of when the ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...